In the past one year, the Nifty Pharma Index has shed 12.4% as against the 1% gains in the benchmark Nifty 50. Mutual Funds that bet on pharma stocks have fallen 14.2% on an average in the past one year. So far in 2022, they have declined 12.4% on an average, according to Value Research.
Bull market has resumed after bottoming out; PSUs will still lead the market but pockets have changed: Ramesh Damani
Ramesh Damani, a BSE member, emphasizes that the bull market has resumed with public sector stocks, particularly in defence and construction, leading the way. He